Opens in a new tab

Advanced Bionics v MED-EL Elektromedizinische Geräte (CFI, 15 April 2024)

Date15 April 2024
CourtCFI
DivisionMannheim (DE) Local Division
Type of actionGeneric application
Registry referenceApp_12139/2024 · ORD_13321/2024
PartiesAdvanced Bionics GmbH, Advanced Bionics AG, Advanced Bionics Sarl

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By an order of 15 April 2024 (UPC_CFI_410/2023, ACT_12139/2024), the President of the Court of First Instance, Florence Butin, having consulted the panel of the Mannheim Local Division (Rule 323.3 RoP), refused the application by Advanced Bionics AG, Advanced Bionics GmbH and Advanced Bionics Sarl, defendants in the infringement action on EP 4 074 373 brought by MED-EL Elektromedizinische Geräte Gesellschaft m.b.H., to change the language of the proceedings from German to English. The order accepts an application lodged before the statement of defence but requires a concrete disadvantage.

Question

Is an application to change the language under Art. 49(5) UPCA admissible before the statement of defence, and have the defendants shown sufficient grounds of fairness?

Decision

The application is admissible: Rule 323 RoP sets a latest deadline, and the efficiency objective in the preamble to the Rules supports early filing. It fails on the merits. The President weighed the parties’ interests in the light of fairness. Parallel proceedings, the use of an English patent attorney and internal group practices stem from the defendants’ strategic choices and do not significantly affect the conduct of the defence. Two defendants are seated in German-speaking countries and the third is an affiliate. No financial imbalance or case-specific disadvantage was shown, and cost and inconvenience alone are not enough. Costs are reserved to the main proceedings. An appeal lies within 15 days (Art. 73(2)(a) UPCA and Rule 220.1(c) RoP).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Art. 41(1), Art. 49(1) to (5) and Art. 73(2)(a)
Rules of Procedure
Rules 23, 220.1(c), 271.7, 321.1, 322 and 323
Case law cited
The Hague Local Division, 18 October 2023, UPC_CFI_225/2023, Aarke v SodaStream Industries, Düsseldorf Local Division, 16 January 2024

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Written procedure (UPC), Court fees and costs (UPC).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Generic application
Outcome (Dhenne Avocats summary)
La demande des défenderesses tendant à faire de l'anglais la langue de procédure est recevable avant le mémoire en défense mais rejetée, faute de désavantage concret pour leur défense.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 4 074 373
Mri-safe disk magnet for implants
recorded proprietor: MED EL Elektromedizinische Geraete GmbH
Mentioned in the analysis (role not qualified)
Also mentioned in 9 other decision(s): Advanced Bionics v MED-EL Elektromedizinische Geräte (CFI, 26 December · MED-EL Elektromedizinische Geräte v Zhejiang Nurotron Biotechnology (C · MED-EL Elektromedizinische Geräte v Zhejiang Nurotron Biotechnology (C · Advanced Bionics v MED-EL Elektromedizinische Geräte (CoA, 3 July 2025 · MED-EL v Advanced Bionics (CFI, 28 May 2025) · Advanced Bionics v MED-EL Elektromedizinische Geräte Gesellschaft m.b. · Advanced Bionics v MED-EL Elektromedizinische Geräte Gesellschaft m.b. · MED-EL Elektromedizinische Geräte Gesellschaft m.b.H. v Advanced Bioni
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.